These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 16998787)

  • 1. Impact of antinucleants on transdermal delivery of testosterone from a spray.
    Leichtnam ML; Rolland H; Wüthrich P; Guy RH
    J Pharm Sci; 2007 Jan; 96(1):84-92. PubMed ID: 16998787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of transdermal testosterone delivery by supersaturation.
    Leichtnam ML; Rolland H; Wüthrich P; Guy RH
    J Pharm Sci; 2006 Nov; 95(11):2373-9. PubMed ID: 16886189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation and evaluation of a testosterone transdermal spray.
    Leichtnam ML; Rolland H; Wüthrich P; Guy RH
    J Pharm Sci; 2006 Aug; 95(8):1693-702. PubMed ID: 16795012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of penetration enhancers for testosterone transdermal delivery from spray formulations.
    Leichtnam ML; Rolland H; Wüthrich P; Guy RH
    J Control Release; 2006 Jun; 113(1):57-62. PubMed ID: 16677734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation issues associated with transdermal fentanyl delivery.
    Santos P; Watkinson AC; Hadgraft J; Lane ME
    Int J Pharm; 2011 Sep; 416(1):155-9. PubMed ID: 21723931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of stability and skin permeation by sucrose stearate and cyclodextrins in progesterone nanoemulsions.
    Klang V; Matsko N; Zimmermann AM; Vojnikovic E; Valenta C
    Int J Pharm; 2010 Jun; 393(1-2):152-60. PubMed ID: 20434531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unique structure and property of cyclodextrins and their application in transdermal drug delivery.
    Hu J; Tao Z; Cao S
    Methods Find Exp Clin Pharmacol; 2009 Sep; 31(7):449-56. PubMed ID: 19907720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationalising polymer selection for supersaturated film forming systems produced by an aerosol spray for the transdermal delivery of methylphenidate.
    Edwards A; Qi S; Liu F; Brown MB; McAuley WJ
    Eur J Pharm Biopharm; 2017 May; 114():164-174. PubMed ID: 28159724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microemulsion formulations for the transdermal delivery of testosterone.
    Hathout RM; Woodman TJ; Mansour S; Mortada ND; Geneidi AS; Guy RH
    Eur J Pharm Sci; 2010 Jun; 40(3):188-96. PubMed ID: 20304048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation and optimization of desogestrel transdermal contraceptive patch using crystallization studies.
    Sachdeva V; Bai Y; Kydonieus A; Banga AK
    Int J Pharm; 2013 Jan; 441(1-2):9-18. PubMed ID: 23262424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physical stability of the amorphous state of loperamide and two fragment molecules in solid dispersions with the polymers PVP-K30 and PVP-VA64.
    Weuts I; Kempen D; Decorte A; Verreck G; Peeters J; Brewster M; Van den Mooter G
    Eur J Pharm Sci; 2005 Jun; 25(2-3):313-20. PubMed ID: 15911228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of formulation excipients on the penetration and lateral diffusion of ibuprofen on and within the stratum corneum following topical application to humans.
    Gee CM; Watkinson AC; Nicolazzo JA; Finnin BC
    J Pharm Sci; 2014 Mar; 103(3):909-19. PubMed ID: 24421242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delivery of ethinylestradiol from film forming polymeric solutions across human epidermis in vitro and in vivo in pigs.
    Zurdo Schroeder I; Franke P; Schaefer UF; Lehr CM
    J Control Release; 2007 Apr; 118(2):196-203. PubMed ID: 17289207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of skin permeation of bufalin by limonene via reservoir type transdermal patch: formulation design and biopharmaceutical evaluation.
    Yang Z; Teng Y; Wang H; Hou H
    Int J Pharm; 2013 Apr; 447(1-2):231-40. PubMed ID: 23467076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation of a reservoir-type testosterone transdermal delivery system.
    Kim MK; Zhao H; Lee CH; Kim DD
    Int J Pharm; 2001 May; 219(1-2):51-9. PubMed ID: 11337165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic enhancement of testosterone transdermal delivery.
    Nicolazzo JA; Morgan TM; Reed BL; Finnin BC
    J Control Release; 2005 Apr; 103(3):577-85. PubMed ID: 15820405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of a screening method to determine excipients which optimize the extent and stability of supersaturated drug solutions and application of this system to solid formulation design.
    Vandecruys R; Peeters J; Verreck G; Brewster ME
    Int J Pharm; 2007 Sep; 342(1-2):168-75. PubMed ID: 17573214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increase of the transdermal penetration of testosterone by miconazole nitrate.
    Baert B; Roche N; Burvenich C; De Spiegeleer B
    Arch Pharm Res; 2012 Dec; 35(12):2163-70. PubMed ID: 23263811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stabilization of low glass transition temperature indomethacin formulations: impact of polymer-type and its concentration.
    Chokshi RJ; Shah NH; Sandhu HK; Malick AW; Zia H
    J Pharm Sci; 2008 Jun; 97(6):2286-98. PubMed ID: 17879977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential scanning calorimetry isothermal hold times can impact interpretations of drug-polymer dispersability in amorphous solid dispersions.
    DeBoyace K; Zdaniewski C; Wildfong PLD
    J Pharm Biomed Anal; 2018 Feb; 150():43-50. PubMed ID: 29216584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.